DKK 4.22
(2.93%)
Year | Operating Income | Operating Income Growth |
---|---|---|
2023 | 16.62 Million DKK | 12.79% |
2022 | 14.74 Million DKK | 35.57% |
2021 | 10.87 Million DKK | 82.29% |
2020 | 5.96 Million DKK | 53.04% |
2019 | 3.89 Million DKK | 0.0% |
Year | Operating Income | Operating Income Growth |
---|---|---|
2024 Q2 | 2.29 Million DKK | 0.0% |
2024 Q1 | 2.29 Million DKK | -41.74% |
2023 Q4 | 3.94 Million DKK | 100.0% |
2023 Q1 | 6.34 Million DKK | -28.73% |
2023 FY | 16.62 Million DKK | 12.79% |
2023 Q3 | 1.97 Million DKK | -84.45% |
2023 Q2 | 12.68 Million DKK | 100.01% |
2022 Q4 | 8.89 Million DKK | 100.0% |
2022 FY | 14.74 Million DKK | 35.57% |
2022 Q3 | 4.44 Million DKK | -23.89% |
2022 Q2 | 5.84 Million DKK | 100.0% |
2022 Q1 | 2.92 Million DKK | 64.71% |
2021 Q1 | 3.66 Million DKK | 0.0% |
2021 FY | 10.87 Million DKK | 82.29% |
2021 Q4 | 1.77 Million DKK | 0.0% |
2021 Q3 | 1.77 Million DKK | -51.56% |
2021 Q2 | 3.66 Million DKK | 0.0% |
2020 FY | 5.96 Million DKK | 53.04% |
2019 FY | 3.89 Million DKK | 0.0% |
Name | Operating Income | Operating Income Difference |
---|---|---|
Ambu A/S | 645 Million DKK | 97.422% |
ChemoMetec A/S | 178.78 Million DKK | 90.7% |
Demant A/S | 4.14 Billion DKK | 99.599% |
GN Store Nord A/S | 869 Million DKK | 98.087% |
ViroGates A/S | -12.56 Million DKK | 232.325% |